Ligand Pharmaceuticals Stock Price

0.76 (0.52%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Ligand Pharmaceuticals Incorporated LGND NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.76 0.52% 146.76 18:00:05
Open Price Low Price High Price Close Price Prev Close
145.25 143.43 147.97 146.76 146.00
Bid Price Ask Price Spread News
143.00 163.00 20.00 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,171 131,139 $ 145.42 $ 19,070,648 349,615 78.26 - 219.75
Last Trade Time Type Quantity Stock Price Currency
17:59:23 4 $ 143.00 USD

Ligand Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.36B 16.08M 9.31M $ 120.28M $ -9.03M 30.33 -261.27
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Ligand Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LGND Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week145.16153.69142.16148.61106,4111.601.1%
1 Month163.91164.79139.00150.71135,170-17.15-10.46%
3 Months163.28219.75131.01169.20546,899-16.52-10.12%
6 Months92.98219.7578.26138.92464,53253.7857.84%
1 Year92.13219.7578.26125.86375,24354.6359.3%
3 Years168.06278.6257.24133.22429,952-21.30-12.67%
5 Years128.73278.6257.24130.15370,51518.0314.01%

Ligand Pharmaceuticals Description

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Your Recent History
Ligand Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.